Nury Tatiana Rincón Cuenca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nury Tatiana Rincón Cuenca has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Andrés Felipe Herrera Ortiz
Department of Radiology, Fundación Santa Fe de Bogotá, Bogota, Colombia
5 shared publications - Santiago Aristizábal-Ortiz
The University of Texas Health Science Center at Houston, Houston, United States
2 shared publications - Valeria del Castillo
Radiology, Fundación Santa Fe de Bogotá, Bogotá, Colombia
2 shared publications - Angela Guarnizo
Diagnostic Neuroradiology Unit, Department of Radiology, Fundación Santa Fe de Bogotá, Bogotá, Colombia
1 shared publication - Angie Melissa Montoya Caro
Department of Medicine, Universidad de Los Andes, Bogotá, Colombia
1 shared publication Angélica M. Sanabria Cano
Fundación Universitaria Sanitas, Bogotá, Colombia
1 shared publication
Latest Publications
- Open Access
- 26 June 2026
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 17, 374
Prevalence of chameleons in patients with ischemic stroke: A cross-sectional study
Background: Stroke is a leading cause of mortality and disability worldwide, with timely identification being crucial for effective treatment. However, some patients present as “stroke chameleons” (SC) displaying atypical stroke symptoms that mimic other conditions, often leading to delayed diagnosis and poorer outcomes. This study aims to assess the prevalence and clinical characteristics of SC in a comprehensive stroke center in Colombia. Methods: This cross-sectional study involved ischemic stroke patients admitted to a high-level medical center in Bogotá, Colombia, from January 1, 2021, to December 31, 2023. We identified SC, defined as patients with a confirmed acute stroke in whom a stroke was not initially suspected, as indicated by a negative Cincinnati prehospital stroke scale and no activation of the stroke protocol. We evaluated the proportion of SC, their clinical and imaging characteristics, and compared them with non-SC patients. Results: Among 635 ischemic stroke patients, 78 (12.2%) were identified as SC, while 557 (87.8%) were identified as non-SC. SC exhibited a lower National Institutes of Health stroke scale score and were more likely to present with altered mental status (38% vs. 24%, p = 0.008), dizziness (30% vs. 16%, p = 0.004), and behavioral changes (8% vs. 2%, p = 0.005). SC displayed less middle cerebral artery involvement (24% vs. 56%, p = 0.047) and more multi-territory involvement (34% vs. 17%, p <0.001). In addition, SC had a higher rate of normal computed tomography scans. Conclusion: SC are a significant subset of ischemic strokes, presenting with atypical symptoms that complicate the diagnosis. Recognizing these non-traditional presentations is essential for timely diagnosis, treatment, and potentially improved outcomes.
- 26 June 2026
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 17, 374
Open AccessPrevalence of chameleons in patients with ischemic stroke: A cross-sectional study
Background: Stroke is a leading cause of mortality and disability worldwide, with timely identification being crucial for effective treatment. However, some patients present as “stroke chameleons” (SC) displaying atypical stroke symptoms that mimic other conditions, often leading to delayed diagnosis and poorer outcomes. This study aims to assess the prevalence and clinical characteristics of SC in a comprehensive stroke center in Colombia. Methods: This cross-sectional study involved ischemic stroke patients admitted to a high-level medical center in Bogotá, Colombia, from January 1, 2021, to December 31, 2023. We identified SC, defined as patients with a confirmed acute stroke in whom a stroke was not initially suspected, as indicated by a negative Cincinnati prehospital stroke scale and no activation of the stroke protocol. We evaluated the proportion of SC, their clinical and imaging characteristics, and compared them with non-SC patients. Results: Among 635 ischemic stroke patients, 78 (12.2%) were identified as SC, while 557 (87.8%) were identified as non-SC. SC exhibited a lower National Institutes of Health stroke scale score and were more likely to present with altered mental status (38% vs. 24%, p = 0.008), dizziness (30% vs. 16%, p = 0.004), and behavioral changes (8% vs. 2%, p = 0.005). SC displayed less middle cerebral artery involvement (24% vs. 56%, p = 0.047) and more multi-territory involvement (34% vs. 17%, p <0.001). In addition, SC had a higher rate of normal computed tomography scans. Conclusion: SC are a significant subset of ischemic strokes, presenting with atypical symptoms that complicate the diagnosis. Recognizing these non-traditional presentations is essential for timely diagnosis, treatment, and potentially improved outcomes.
- Open Access
- 30 August 2023
- Published by Principles and Practice of Clinical Research in Principles and Practice of Clinical Research Journal
- Vol. 9 (2)
Inflammasomes as a Prognostic Marker and Possible Therapeutic Target in Multiple Sclerosis: A Rapid Review of the Literature
Introduction: Inflammasomes are multiprotein complexes innate to the immune system that, upon activation, initiate a chain reaction culminating in the production of cytokines IL-1 and IL-18. Recent studies have suggested a connection between inflammasome activation and neurological diseases such as multiple sclerosis (MS). In this review, we aimed to evaluate the role of inflammasomes as potential therapeutic agents and prognostic markers of MS. Methods: Through a database search, 156 articles were identified. Of these, we selected articles focusing on observational and interventional studies that either directly measured the expression of inflammasomes or the levels of cytokines or interleukin as outcomes. After applying a snowball sampling strategy, this review ultimately included nine studies. Results: Our search yielded nine studies published between 2010 and 2022—9 observational studies included case-control and cohort designs. All studies comprised adult populations, 20–72 years of age. All studies incorporated a control group. We selected studies that utilized surrogate measures to evaluate outcomes such as inflammasome expression of NLRP3 or similar genes and assess cytokine levels such as IL-1β, IL-18, IL-23, and TNF. Discussion: Overall, the revised studies suggest a possible role for inflammasomes components, including ASC and caspase-1, which have been evaluated as potential prognostic markers in MS. Therapeutic strategies have focused on the inhibition of NLRP3, which is one of the most prominent and studied inflammasomes, by IFN-β.
- 30 August 2023
- Published by Principles and Practice of Clinical Research in Principles and Practice of Clinical Research Journal
- Vol. 9 (2)
Open AccessInflammasomes as a Prognostic Marker and Possible Therapeutic Target in Multiple Sclerosis: A Rapid Review of the Literature
Introduction: Inflammasomes are multiprotein complexes innate to the immune system that, upon activation, initiate a chain reaction culminating in the production of cytokines IL-1 and IL-18. Recent studies have suggested a connection between inflammasome activation and neurological diseases such as multiple sclerosis (MS). In this review, we aimed to evaluate the role of inflammasomes as potential therapeutic agents and prognostic markers of MS. Methods: Through a database search, 156 articles were identified. Of these, we selected articles focusing on observational and interventional studies that either directly measured the expression of inflammasomes or the levels of cytokines or interleukin as outcomes. After applying a snowball sampling strategy, this review ultimately included nine studies. Results: Our search yielded nine studies published between 2010 and 2022—9 observational studies included case-control and cohort designs. All studies comprised adult populations, 20–72 years of age. All studies incorporated a control group. We selected studies that utilized surrogate measures to evaluate outcomes such as inflammasome expression of NLRP3 or similar genes and assess cytokine levels such as IL-1β, IL-18, IL-23, and TNF. Discussion: Overall, the revised studies suggest a possible role for inflammasomes components, including ASC and caspase-1, which have been evaluated as potential prognostic markers in MS. Therapeutic strategies have focused on the inhibition of NLRP3, which is one of the most prominent and studied inflammasomes, by IFN-β.
- Open Access
- 30 June 2023
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 14, 222
Prevalence and risk factors of unruptured intracranial aneurysms in ischemic stroke patients – A global meta-analysis
Background: Unruptured intracranial aneurysms (UIAs) have an estimated global prevalence of 2.8% in the adult population; however, UIA was identified among more than 10% of ischemic stroke patients. Many epidemiological studies and reviews have pointed to the presence of UIA among patients with ischemic stroke; yet, the extent of this association is not fully known. We performed a systematic review and meta-analysis to determine the prevalence of UIA in patients admitted to hospitals with ischemic stroke and transient ischemic attack (TIA) at both global and continental levels and evaluate factors associated with UIA in this population. Methods: We identified, in five databases, all studies describing UIA in ischemic stroke and TIA patients between January 1, 2000, and December 20, 2021. Included studies were of observational and experimental design. Results: Our search yielded 3581 articles of which 23 were included, with a total of 25,420 patients. The pooled prevalence of UIA was 5% (95% confidence interval [CI] = 4–6%) with stratified results showing 6% (95% CI = 4–9%), 6% (95% CI = 5–7%), and 4% (95% CI = 2–5%) in North America, Asia, and Europe, respectively. Significant risk factors were large vessel occlusion (odds ratios [OR] = 1.22, 95% CI = 1.01–1.47) and hypertension (OR = 1.45, 95% CI = 1.24–1.69), while protective factors were male sex (OR = 0.60, 95% CI = 0.53–0.68) and diabetes (OR = 0.82, 95% CI = 0.72–0.95). Conclusion: The prevalence of UIA is notably higher in ischemic stroke patients than the general population. Physicians should be aware of common risk factors in stroke and aneurysm formation for appropriate prevention.
- 30 June 2023
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 14, 222
Open AccessPrevalence and risk factors of unruptured intracranial aneurysms in ischemic stroke patients – A global meta-analysis
Background: Unruptured intracranial aneurysms (UIAs) have an estimated global prevalence of 2.8% in the adult population; however, UIA was identified among more than 10% of ischemic stroke patients. Many epidemiological studies and reviews have pointed to the presence of UIA among patients with ischemic stroke; yet, the extent of this association is not fully known. We performed a systematic review and meta-analysis to determine the prevalence of UIA in patients admitted to hospitals with ischemic stroke and transient ischemic attack (TIA) at both global and continental levels and evaluate factors associated with UIA in this population. Methods: We identified, in five databases, all studies describing UIA in ischemic stroke and TIA patients between January 1, 2000, and December 20, 2021. Included studies were of observational and experimental design. Results: Our search yielded 3581 articles of which 23 were included, with a total of 25,420 patients. The pooled prevalence of UIA was 5% (95% confidence interval [CI] = 4–6%) with stratified results showing 6% (95% CI = 4–9%), 6% (95% CI = 5–7%), and 4% (95% CI = 2–5%) in North America, Asia, and Europe, respectively. Significant risk factors were large vessel occlusion (odds ratios [OR] = 1.22, 95% CI = 1.01–1.47) and hypertension (OR = 1.45, 95% CI = 1.24–1.69), while protective factors were male sex (OR = 0.60, 95% CI = 0.53–0.68) and diabetes (OR = 0.82, 95% CI = 0.72–0.95). Conclusion: The prevalence of UIA is notably higher in ischemic stroke patients than the general population. Physicians should be aware of common risk factors in stroke and aneurysm formation for appropriate prevention.
- Open Access
- 24 November 2022
- Published by Elsevier in Radiology Case Reports
- Vol. 18 (2) , 515-518
Multiple sclerosis with megacystic presentation: A case report
- 24 November 2022
- Published by Elsevier in Radiology Case Reports
- Vol. 18 (2) , 515-518
Open AccessMultiple sclerosis with megacystic presentation: A case report
- Open Access
- 20 June 2022
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (9) , 3035-3039
Diagnostic approach to Aicardi syndrome: A case report
- 20 June 2022
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (9) , 3035-3039
Open AccessDiagnostic approach to Aicardi syndrome: A case report
- Open Access
- 17 February 2022
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (4) , 1288-1292
Computed tomography findings of Crouzon syndrome: A case report
- 17 February 2022
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (4) , 1288-1292
Open AccessComputed tomography findings of Crouzon syndrome: A case report